Bernhardt v. Pfizer, Inc.
United States District Court for the Southern District of New York
2000 WL 1738645 (2000)

- Written by Mary Phelan D'Isa, JD
Facts
Lawrence D. Bernhardt and Arnold Liebman (plaintiffs), users of Cardura, the brand-named drug for antihypertensive doxazosin, sued its manufacturer, Pfizer, Inc. (defendant), for products liability. Bernhardt and Liebman sought an injunction ordering Pfizer to notify Cardura users and their physicians about the results of a National Institute of Health (NIH) study questioning the efficacy of doxazosin versus the widely used diuretic drug chlorthalidone to reduce some forms of cardiovascular disease. Bernhardt and Liebman sought the injunction in their motion for judgment on the pleadings under Federal Rule of Civil Procedure 12(c).
Rule of Law
Issue
Holding and Reasoning (McKenna, J.)
What to do next…
Here's why 815,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.